醫(yī)學(xué)寄生蟲學(xué):利什曼原蟲 LEISHMANIA_第1頁
醫(yī)學(xué)寄生蟲學(xué):利什曼原蟲 LEISHMANIA_第2頁
醫(yī)學(xué)寄生蟲學(xué):利什曼原蟲 LEISHMANIA_第3頁
醫(yī)學(xué)寄生蟲學(xué):利什曼原蟲 LEISHMANIA_第4頁
醫(yī)學(xué)寄生蟲學(xué):利什曼原蟲 LEISHMANIA_第5頁
已閱讀5頁,還剩45頁未讀, 繼續(xù)免費(fèi)閱讀

下載本文檔

版權(quán)說明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請進(jìn)行舉報(bào)或認(rèn)領(lǐng)

文檔簡介

1、利什曼原蟲 LEISHMANIA2015-12-22LeishmaniaAn obligate intro-macrophage & -DC cellsMore than 20 speciesTransmitted to human by 30 species of plebotomine sandflies.CONCEPTIONLeishmaniasis (利氏曼?。㏒preading in 88 countries, 22 New World 66 Old WorldVector:Sandfly (白蛉)Occurring in several forms, visceral form :

2、內(nèi)臟型cutaneous form :皮膚型Mucocutaneous:粘膜皮膚型人獸共患病History dating back as far as the first century AD. Ecuador and Peru “skin lesions and facial deformities “, William Leishman, 1901, discovered ovoid bodies in the spleen of a British soldier Published as “dum-dum fever”Charles Donovan published his disc

3、overy symptoms in other kala-azar patients a few weeks after Leishman. in 1903. These amastigotes were known as Leishman-Donovan bodies and officially, this species became known as, L. Donovani. 3、19241926年外國學(xué)者Cash在中國調(diào)查發(fā)現(xiàn):中國地鼠易感; 在昆蟲白蛉體內(nèi)無鞭毛體轉(zhuǎn)變發(fā)育成前鞭毛體, 并大量繁殖 鐘惠瀾 (PUMC) : 1942年經(jīng)白蛉叮咬志愿受試者,感染成功 。History

4、Five Characteristics Invading and living in MacrophagesReside in phagolysosomes of the cell Appearing markedly different clinical manifestationsHuman host genetic makeup and/or nutritional state to the course of infection have yet been described completely. “Successful” drug treatment followed a qui

5、te different clinic manifestation such as post-kala-azar dermal leishmanoid. Leishman-Donovan bodiesMorphology of Leishmania amastigotes (無鞭毛體)Scanning electron micrograph of isolated L. amazonensis amastigotes (Membrane remnants of the PV are attached to the posterior pole of the parasite (white ar

6、rowhead).The white arrows indicate the entry of the flagellar pocket (anterior pole). Macrophages were incubated with amastigotes of L. mexicana. At 6 h (A) or 24 h (B)Post contact with purified amastigotes, Note the progressive enlargement of the PVs (white arrows) containing numerousamastigotes.Li

7、ght microscopic Morphology of Leishmania promastigote (前鞭毛體)Trypanosoma & Leishmania are the medically important and best studied genera in this groupTrypanosoma LeishmaniaLeishmania infects and thrives in macrophagesLife circle Leishmania infects and thrives in macrophagesMacrophages are important

8、“microbe killers”, however several pathogens have found ways to escape the killing phagocytosis or active invasion and escapes into the cytoplasm by the parasites:Trypanosoma cruzi ToxoplasmaLeishmaniaClinical syndromesCtaneous leishmaniasis (皮膚型) Diffuse cutaneous leishmaniasis (彌漫性皮膚型)Mucocutaniou

9、s leishmanisis (粘膜皮膚型)Visceral leshmaniasis (VL,kala-azar, 內(nèi)臟型、黑熱病)Three syndromes associated with Leishmania infection in humansCutaneous LeishmaniasisInfection remains restricted to the initial site of infection (the bite site)Cutaneous leishmaniasisOne or more ulcer(s) or nodule(s) in skinDiffere

10、nt species induce variable clinical presentations and prognoses;heal spontaneouslyLeave disfiguring scarsCutaneous leishmaniasisEspundia or mucocutaenous leishmaniasisCaused by L. braziliensis20% of infected patients develop ulcers of the oral and nasal mucosaMuco-cutanious leishmanisis (espundia)pr

11、ogressively destructive ulcerations of themucosa, extending from the nose and mouth to the pharynx and larynx.Not self-healingUsually seen months or years after a first episodeMostly caused by Leishmania braziliensis, responsible for most cases of muco-cutaneous leishmaniasis.Espundia鼻咽粘膜利什曼病 or muc

12、ocutaenous leishmaniasisProgression of the ulceration is slow but steady, ultimately destroying all soft parts of the nose, the lips, and the soft palateDeath can occurs through secondary bacterial infectionSkull damages by EspundiaVisceral Leishmaniasis or Kala-AzarSystemic infection of reticulo-en

13、tdothelial cells (mostly macrophages) throughout multiple internal organs and the bloodVisceral leshmaniasis (VL; kala-azar)systemic disease that is fatal if left untreatedcaused by the Leishmania donovani complex L. donovani sensu stricto in East Africa and the Indian subcontinent Leishmania infant

14、um in Europe, North Africa Latin AmericaThere are two types of VL, differ in their transmission characteristics:Zoonotic 動(dòng)物源性 VLfrom animal (mainly dogs) to vector to human By L. infantum Anthroponotic 人源性VL:from human to vector to humanBy L. donovaniClinical presentation of VL patients Incubation p

15、eriod lasts between 2 and 6 monthsSymptoms and signs of persistent systemic infection: fever, fatigue, weakness, loss of appetite and weight loss;parasitic invasion of the blood and reticulo-endothelial system:enlarged lymph nodes, spleen and liver.Anaemia, bleedingThe ratio of incident asymptomatic

16、 infections to incident clinical cases varies Clinical syndromes of three leishmaniasis A variety of species and species complexes causes disease in humansVisceral LeishmaniasisLeishmania donovaniLeishmania infantumLeishmania chagasiCutaneous LeishmaniasisLeishmania tropicaLeishmania majorLeishmania

17、 aethiopicaMucocutaneous LeishmaniasisLeishmania brazieliensisLeishmania mexicanaLeishmania amazoniensisDiffuse cutaneous leishmaniasisCharacteristic diffusion of lesions, great abundance of parasites, anergy to skin tests with the specific antigen and resistance to treatment. Due, not to a differen

18、t type of parasite, but to an immunological defect of the human host, which makes him respond with these special clinical and parasitological manifestations.anergy Diagnosisvisceral leishmaniasis - taking a blood sample and/or taking a biopsy from the bone marrow to show the parasite. cutaneous leis

19、hmaniasis - small biopsy or scraping of the ulcer. mucocutaneous leishmaniasis - a biopsy of the affected tissues. Biopsy samples are examined by microscopy, culture and other methods to look for the parasite and identify the specific kind of Leishmania causing the ulcer. Some of these methods will

20、give results within a few days, but culture may take 2-4 weeks to demonstrate the parasite. DiagnosisNon-leishmanial tests.A reduction in the number of red and white blood cells and platelets,high titers of non-specific antibody Parasite detection.Amastigote by microscope in spleen bone marrow lymph

21、 nodesPCRAntibody-detection tests.always be used in combination with a standardized clinical case definition for VL diagnosisELISA, IFA,DAT (direct agglutination test)ICT(Rk39-based immunochromatograpphic test) PCRTreatment strategiesfirst-line treatment for VL in many areas for more than 70 years:A

22、ntimonials sodium stibogluconateMeglumine antimoniate 葡萄糖酸銻鈉 戊脘脒 二脒替From 2002, miltefosine (hexadecylphosphocholine, 米替福新),orally administered drug cure 98% VL cases. Epidemiology Epidemiology of Leishmaniasis Threatens about 310 million peopleIn 88 countries around the world. During the past 10 yea

23、rs the disease has spread considerably. An estimated 1.3 million new cases and estimated 20,000 to 30,000 deaths occurs annually. Linked to environmental changes such as deforestation, building of dams, irrigation schemes and urbanization. Epidemiology of LeishmaniasisCurrently, leishmaniasis occurs

24、 in four continents, 72/88 countries are developing countries: 90% of all VL s cases occur in Bangladesh, Brazil, Ethiopia, India, South Sudan and Sudan; 1/3 of CL cases occur in Americas, the Mediterranean basin, and the Middle East and Central Asia. An astimated 0.7 to 1.3 million new cases occur

25、worldwide annually. 90% of mucocutaneous leishmaniasis are reported in Bolivia, Brazil and Peru; (WHO 2013)visceral leishmaniasis in the Old and New worldcutaneous and mucocutaneous leishmaniasis in the New Worldcutaneous leishmaniasis due to L. tropica and related species and L. aethiopicacutaneous

26、 leishmaniasis due to L. majorEcology of old world LeismaniasisIn urban environments infection is mostly human to humanIn rural areas Leishmaniasis can be a zoonosis Infection in dogs is quite frequent in the Mediterranean Ecology of new world leishmaniasisMost people get infected while working or h

27、unting in the forestWild animals provide a reservoir for the parasiteMore than a 1000 American soldiers contacted Leishmaniasis in Iraq !A REGION INFLAMED: Hundreds of U.S. Troops Infected by Parasite Borne by Sand Flies, Army SaysBy DONALD G. MCNEIL JR.Published: December 6, 2003Hundreds of America

28、n troops in Iraq have been infected with a parasite spread by biting sand flies, and the long-term consequences are still unknown, Army doctors said Friday 皮膚型利什曼病1.5 million/y; Afghanistan, Algeria, Iran, Iraq, Saudi Arabia, and Syria and in Brazil and Peru; 一個(gè)中國人從“沙特歸來患上罕見利什曼病 ,表現(xiàn)為全身皮膚潰爛 ” 金陵晚報(bào) 20

29、10-12-07 08:52:27 國內(nèi)流行情況人源型 平原地區(qū) 傳播媒介家棲型中華白蛉和長管白蛉 青少年和壯年犬源型 丘陵山區(qū) 四川阿壩地區(qū)(5.39/10萬) 傳播媒介野棲型中華白蛉 嬰幼兒自然疫源型 荒漠地區(qū) (新疆喀什、和田地區(qū) ) 傳染源野生保蟲宿主 傳播媒介 吳氏白蛉和亞歷山大白蛉 以 幼兒為主 ,成人為淋巴結(jié)型黑熱病國內(nèi)流行情況6省區(qū)始終存在新疆、甘肅、四川、 陜西、山西、內(nèi)蒙古每年新感染患者200-300例(CDC IPD) (新疆南部喀什、和田地區(qū)3歲以下兒童發(fā)病數(shù)百例,癥狀與黑熱病相似,死亡18例,其余均已康復(fù)。1-3月發(fā)病,70%血清rK39陽性 2007)我國黑熱病的特

30、殊臨床表現(xiàn) 皮膚型黑熱病: 面部和頸部皮膚結(jié)節(jié) (平原地區(qū)) 淋巴結(jié)型黑熱病: 淺表淋巴結(jié)腫大 (荒漠地區(qū))7 預(yù)后 (取決于早期特效治療) 未經(jīng)治療死亡率高達(dá)70-90% 特效藥治愈率較高 Vector control Shand fly(attached)(detached)Control strategiesControl strategiesReservoir controlSerological screening of dogs and killing of sero-positive animals.Vector control.Sandflies are susceptible to the sameinsecticidesInsecticide-impregnated materials. The use of insecticide-treated bednets (ITNs)Early diagnosis and treatmen

溫馨提示

  • 1. 本站所有資源如無特殊說明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請下載最新的WinRAR軟件解壓。
  • 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
  • 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁內(nèi)容里面會(huì)有圖紙預(yù)覽,若沒有圖紙預(yù)覽就沒有圖紙。
  • 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
  • 5. 人人文庫網(wǎng)僅提供信息存儲(chǔ)空間,僅對用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對任何下載內(nèi)容負(fù)責(zé)。
  • 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請與我們聯(lián)系,我們立即糾正。
  • 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶因使用這些下載資源對自己和他人造成任何形式的傷害或損失。

評論

0/150

提交評論